1. Dai, Xiaomeng, Lu, Lisen, Deng, Suke, Jin, Honglin, Yang, Kunyu. 2020. USP7 targeting modulates anti-tumor immune response by reprogramming Tumor-associated Macrophages in Lung Cancer. In Theranostics, 10, 9332-9347. doi:10.7150/thno.47137. https://pubmed.ncbi.nlm.nih.gov/32802195/
2. Zhang, Xiao-Wen, Feng, Na, Liu, Yan-Chen, Tu, Peng-Fei, Zeng, Ke-Wu. 2022. Neuroinflammation inhibition by small-molecule targeting USP7 noncatalytic domain for neurodegenerative disease therapy. In Science advances, 8, eabo0789. doi:10.1126/sciadv.abo0789. https://pubmed.ncbi.nlm.nih.gov/35947662/
3. He, Yuanming, Jiang, Shuoyi, Zhong, Yueya, Huang, Zhenqian, Mao, Xinliang. . USP7 promotes non-small-cell lung cancer cell glycolysis and survival by stabilizing and activating c-Abl. In Clinical and translational medicine, 13, e1509. doi:10.1002/ctm2.1509. https://pubmed.ncbi.nlm.nih.gov/38082439/
4. Wang, Zhiru, Kang, Wenting, Li, Ouwen, Zheng, Yichao, Liu, Hong-Min. 2020. Abrogation of USP7 is an alternative strategy to downregulate PD-L1 and sensitize gastric cancer cells to T cells killing. In Acta pharmaceutica Sinica. B, 11, 694-707. doi:10.1016/j.apsb.2020.11.005. https://pubmed.ncbi.nlm.nih.gov/33777676/
5. Manea, Teodora, Nelson, Jessica Kristine, Garrone, Cristina Maria, Behrens, Axel, Sancho, Rocio. 2023. USP7 controls NGN3 stability and pancreatic endocrine lineage development. In Nature communications, 14, 2457. doi:10.1038/s41467-023-38146-9. https://pubmed.ncbi.nlm.nih.gov/37117185/
6. Wang, Nan, Li, Tianzi, Liu, Wanyu, Xu, Meilan, Liu, Xuekui. 2023. USP7- and PRMT5-dependent G3BP2 stabilization drives de novo lipogenesis and tumorigenesis of HNSC. In Cell death & disease, 14, 182. doi:10.1038/s41419-023-05706-2. https://pubmed.ncbi.nlm.nih.gov/36878903/
智鼠故事 
